Gene2Skin - Roadmap for advanced genetic engineering-based skin therapies

I. Alex Vitkin

Optical coherence tomography for assessment of early radiobiological response in-vivo

Melanoma of skin All cancers but non-melanoma skin cancer

Radiation Oncology

Investigator from University of Groningen

Identifying pathways of cellular nanoparticle uptake and early processing for novel nanomedicine applications

Melanoma of skin All cancers but non-melanoma skin cancer

Karlene A Cimprich

Mechanisms Linking Genome Stability to RNA Metabolism

Melanoma of skin All cancers but non-melanoma skin cancer

Benjamin Neel

The Gab/Par pathway in development and cancer

Melanoma of skin All cancers but non-melanoma skin cancer

Noelle Elizabeth Huskey Mullin

The Role of Primary Cilia in the Evolution of Drug Resistant Basal Cell Carcinoma

Melanoma of skin All cancers but non-melanoma skin cancer

Ian Douglas

Developing methodologies for use in observational studies of drug effects using computerised clinical data

Melanoma of skin All cancers but non-melanoma skin cancer

Alan Anderson

Inducible metabolism of xenochemicals and endogenous toxic compounds: Nuclear receptors and the CYP2B paradigm

Melanoma of skin All cancers but non-melanoma skin cancer

Investigator from Helmholtz Zentrum München (HZ)

Mechanisms of Gene Silencing by the Glucocorticoid Receptor

Melanoma of skin All cancers but non-melanoma skin cancer

Deborah Johnson

Maf1, a novel negative transcriptional regulator of the TATA binding protein

Melanoma of skin All cancers but non-melanoma skin cancer